Potentiators of insulin secretion
US8507557B2 · kind B2 · utility
0Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 2010 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Mar 9, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a recognition that an analog of αKG can increase glucose-induced insulin secretion in vitro and in vivo in animals, particularly in mammals, and more particularly in humans and in rodents. By employing the methods of the invention, insulin secretion can be increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.